Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes

Update Il y a 4 ans
Reference: NCT01127269

Woman and Man

  • | Country :
  • Argentina
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Primary Objective: Percentage of patients achieving Glycosylated Hemoglobin (HbA1c) < 7% with no severe or nocturnal hypoglycemic episodes at 6 months Secondary Objectives: - Glycosylated Hemoglobin (HbA1c) change from baseline to 6 months - Insulin glargine dose at 3 and 6 months - Hypoglycemic episodes (all types)


Inclusion criteria

  • Diabetes Mellitus, Type 2

Links